This year's American Academy of Neurology annual meeting takes place April 15-21, 2016 in Vancouver, British Columbia.
Neuro News Roundup: Consequences of Neuro Conditions
Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.
Antiepileptic Drug Choice: Patient vs Neurologist
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
Managing MS and Immunological Comorbidities
How do you approach the management of patients with multiple sclerosis and another autoimmune condition, such as psoriasis?
Carotid Endarterectomy vs Carotid Stenting
A retrospective cohort study of Medicare patients sought to determine if carotid endarterectomy or carotid stenting provided better outcomes.
Important Drug Approval for Parkinson Patients
Nuplazid, which the FDA designated as a breakthrough therapy and granted priority review, could help approximately 50% of Parkinson patients.
Interesting Neuro: Alzheimer & Parkinson insights
Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.
Clinical Trial Highlights: AAN 2016 – Part 1
From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.
Botulinum Toxin: Guideline Updates
Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.
By clicking Accept, you agree to become a member of the UBM Medica Community.